Digwill International Pvt Ltd
Back to catalog
Imjudo (Tremelimumab) Injection
Astra Zeneca Pharma India

Imjudo (Tremelimumab) Injection

Imjudo (Tremelimumab) Injection is a cancer medicine. It is used to treat: hepatocellular carcinoma (a type of liver cancer) in adult patients who have not been treated before and whose disease is advanced or unresectable (cannot be removed by surgery). It is used in combination with durvalumab, another cancer medicine; non-small cell lung cancer (NSCLC) that has metastasised (spread to other parts of the body) in adult patients who have not been treated before. It is given together with durvalumab and platinum-based chemotherapy and is used when the cancer has shown no mutations (changes) in the so-called EGFR and ALK. It contains the active substance Tremelimumab. Imjudo is a prescription medication that must be administered in your doctor’s office. Generic Tremelimumab Injection (Brand

Therapy areaAstra Zeneca Pharma India
AvailabilityAvailable on order · Bulk enquiries welcome
DistributionPan-India · Cold-chain compliant
Request quotation

About Imjudo (Tremelimumab) Injection

Description Is Tremelimumab available in India? Yes, Tremelimumab is available in India. It is marketed under the brand name Imjudo. It is a fully human monoclonal antibody used for the treatment of hepatocellular carcinoma (a type of liver cancer). The most common side effects when used in combination with durvalumab include rash, pruritus (itching), diarrhea, abdominal (belly) pain, increased levels of liver enzymes, fever, hypothyroidism (an underactive thyroid gland), cough, peripheral edema (swelling especially of the ankles and feet) and increased level of lipase (an enzyme that helps digest fat, mainly made in the pancreas). Tremelimumab was approved for medical use in the United States in October 2022, and in the European Union in February 2023. Who is the CFA, distributor, and retailer for Imjudo (Tremelimumab) Injection in India? Aark Pharmaceuticals is an authorized distributor, CFA (Carry and Forward Agent), and retailer for Imjudo (Tremelimumab) Injection in India. It is marketed by AstraZeneca . Aark claims to provide 100% authentic, cold-chain managed medicines. Aark supplies a wide range of AstraZeneca products , including advanced cancer treatments. The company serves hospitals, clinics, and patients across India, including major cities like Bangalore, Surat, Kolkata, Indore, Nagpur, Patiala, Srinagar, Ahmedabad, Osmanabad, Mumbai, Pune, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Coimbatore, Kochi, Kollam, Agartala, Lucknow, Dehradun, Gairsain, Aizawal, Aurangabad, Barshi, Karungapally, Pondichery, Punjab, Delhi, New Delhi, Agra, Kanpur, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad, Wardha, Bhopal, Manipur, Mizoram, Sikkim, Tripura, Arunachal, Meghalaya, Nagaland, Pasighat, Cachar, Dibrugarh, Kamrup. How much do Imjudo Injection cost in Delhi, India? Prices may vary based on your prescribed treatment plan. For accurate and the most cost-effective pricing on your prescription-recommended product, please contact Aark Pharmaceuticals Seller Name: Aark Pharmaceuticals Private Limited. Contact Person: Ms. Himanshi Address: S-14, Ground & Ist Floor, Green Park Extn., New Delhi-110016. Mobile / WhatsApp : 9999156233 Email: sales@aarkpharma.co.in , sales@aarkpharma.com Our Branch Offices in India – New Delhi | Lucknow | Varanasi | Chandigarh | Kolkata | Patna | Jodhpur. Do you offer any discounts? Yes. Based on availability, prices may vary based on your prescribed treatment plan. Please ask for the best current price. Prior to consuming any medications, including Tremelimumab Injection, it is advisable to seek guidance from a medical professional regarding its therapeutic advantages, usage instructions, and potential side effects. Written By Mr. Sandeep Tomar (D. pharma) Last updated 10 June 2026 | 10:10 AM (IST)

Related products